Search

To address the problems of wind and solar generation volatility and lose of wind and photovoltaic resources, on the basis of the complementary property of wind-solar-water, the topology structure of the wind-solar-water synergy power generation system is constructed. Taking the minimum grid fluctuation index, the minimum wind-photovoltaic-hydro discard rate and the greatest economic effectiveness of the power station as the goal functions and considering various constraints of the wind, photovoltaic, and hydrostation units, a triobjective optimization running model of the wind-photovoltaic-water synergy system is established. Meanwhile, this essay suggests an IMOSSA on the basis of tent chaotic sequence and random wandering strategy to settle the described triobjective optimization issue. Taking Hubei Pankou as an example for simulation analysis, after choosing the best scheme, IMOSSA compared with MOSSA, MOGWO, and NSGA-II, the volatility of sunny days is reduced by 12.39%, 19.5%, and 36.71%, respectively; the wind-photovoltaic abandonment rate is reduced by 11.17%, 22.5%, and 38.03%, respectively, while in the rainy days the volatility is reduced by 8.09%, 18.34%, and 47.03%, respectively; the wind-photovoltaic abandonment rate is reduced by 14.84%, 16.86%, and 40%, respectively. Therefore, it is possible to demonstrate the validity of the proposed three-objective model and the efficiency of the IMOSSA in solving the issue. The efficiency of the optimization operation approach suggested in this research is confirmed by the case study, providing a new idea for the large-scale consumption of new energy in high-proportion hydropower grids. [ABSTRACT FROM AUTHOR]

Electrolytic capacitors are the components that mainly impact the lifetime of ac/dc light-emitting diode (LED) drivers. Therefore, eliminating electrolytic capacitors from LED drivers is of vital importance. First, the basic derivation concept of a family of flyback-based three-port converters for electrolytic capacitor-less LED drivers is addressed in this paper, by manipulating the power flow among input port, output port, and storage capacitors. Together with the derivation of existing topologies, new topologies are also proposed. After evaluation, an integrated dual flyback converter (IDFC) is chosen, which requires less switching components and simpler control strategy. Following that, the operation principle and switching modes of the IDFC are elaborated, as well as the parameter design and implementation of control strategy. Finally, experiments on a laboratory prototype are carried out to verify the feasibility of the proposed topology. [ABSTRACT FROM PUBLISHER]

Long-term dual antiplatelet therapy (DAPT) has substantially reduced the risk of post-percutaneous coronary intervention (PCI) myocardial infarction and stent thrombosis at the expense of major bleeding. We hypothesized that a short-term DAPT followed by extended P2Y 12 inhibitor monotherapy might be appropriate for patients with both high ischemic and bleeding risks. We searched the databases: Pubmed, EMBASE, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov to identify randomized trials assessing the antiplatelet strategies after PCI. The primary safety endpoint was Bleeding Academic Research Consortium (BARC) type 3 or 5 bleeding. The efficacy outcome was a composite of all-cause mortality/cardiovascular disease (CVD) death, myocardial infarction, or stroke. A random-effect model was used to calculate the pooled hazard ratios (HRs) with 95% confidence intervals (CIs). We identified 5 randomized trials comparing P2Y 12 inhibitor monotherapy with standard DAPT (12 months) (16,057 versus 16,088). P2Y 12 inhibitor monotherapy following short-term DAPT (1 to 3 months) significantly reduced the risk of BARC type 3 or 5 bleeding compared to standard DAPT (pooled HR: 0.63, 95%CI: 0.46–0.86). The difference between P2Y 12 inhibitor monotherapy and standard DAPT in reducing the composite CVD outcomes was not statistically significant (HR: 0.88, 95%CI: 0.77–1.01). P2Y 12 inhibitor monotherapy might be an effective strategy for lowering severe bleeding complications and simultaneously preserving the ischemic benefit in patients receiving PCI. • Long-term DAPT reduced the risk of post-PCI myocardial infarction and stent thrombosis at the cost of major bleeding. • The P2Y 12 inhibitors reduced the risk of recurrent ischemic events with similar or less bleeding risk compared to aspirin. • P2Y 12 inhibitor monotherapy after short-term DAPT can be used for patients with both high ischemic and bleeding risks. [ABSTRACT FROM AUTHOR]